Fenqin Chen

895 total citations
18 papers, 674 citations indexed

About

Fenqin Chen is a scholar working on Molecular Biology, Nephrology and Physiology. According to data from OpenAlex, Fenqin Chen has authored 18 papers receiving a total of 674 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 5 papers in Nephrology and 5 papers in Physiology. Recurrent topics in Fenqin Chen's work include Chronic Kidney Disease and Diabetes (4 papers), Advanced Glycation End Products research (3 papers) and Alzheimer's disease research and treatments (2 papers). Fenqin Chen is often cited by papers focused on Chronic Kidney Disease and Diabetes (4 papers), Advanced Glycation End Products research (3 papers) and Alzheimer's disease research and treatments (2 papers). Fenqin Chen collaborates with scholars based in China and United States. Fenqin Chen's co-authors include Tianxing Wu, Honggang Tang, Xiaodong Pan, Qiuyue Wang, Xiaoyu Ma, Ting Huang, Ying Shao, Chuan Lv, Can Wu and Jiao Xu and has published in prestigious journals such as BMC Public Health, Oxidative Medicine and Cellular Longevity and Molecular and Cellular Endocrinology.

In The Last Decade

Fenqin Chen

18 papers receiving 647 citations

Peers

Fenqin Chen
Hsin‐Yi Yang Taiwan
Kohji Ohki Japan
Yu‐Ling Tsai Taiwan
Wanping Aw Japan
Chu‐Chyn Ou Taiwan
Farhad Koohpeyma Iran
Jing Zhong China
Nana Wang China
Hsin‐Yi Yang Taiwan
Fenqin Chen
Citations per year, relative to Fenqin Chen Fenqin Chen (= 1×) peers Hsin‐Yi Yang

Countries citing papers authored by Fenqin Chen

Since Specialization
Citations

This map shows the geographic impact of Fenqin Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fenqin Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fenqin Chen more than expected).

Fields of papers citing papers by Fenqin Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fenqin Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fenqin Chen. The network helps show where Fenqin Chen may publish in the future.

Co-authorship network of co-authors of Fenqin Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Fenqin Chen. A scholar is included among the top collaborators of Fenqin Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fenqin Chen. Fenqin Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Fan, Yan, et al.. (2025). Novel anti-inflammatory properties of mannose oligosaccharides in the treatment of inflammatory bowel disease via LGALS3 modulation. npj Biofilms and Microbiomes. 11(1). 26–26. 1 indexed citations
2.
Chen, Fenqin, Jun Bai, Shanshan Zhong, et al.. (2022). Molecular Signatures of Mitochondrial Complexes Involved in Alzheimer’s Disease via Oxidative Phosphorylation and Retrograde Endocannabinoid Signaling Pathways. Oxidative Medicine and Cellular Longevity. 2022(1). 9565545–9565545. 18 indexed citations
3.
Ma, Xiaoyu & Fenqin Chen. (2021). Effects of anti-diabetic drugs on sarcopenia: Best treatment options for elderly patients with type 2 diabetes mellitus and sarcopenia. World Journal of Clinical Cases. 9(33). 10064–10074. 15 indexed citations
4.
Zhou, Zhike, Fenqin Chen, Shanshan Zhong, et al.. (2020). Molecular identification of protein kinase C beta in Alzheimer's disease. Aging. 12(21). 21798–21808. 11 indexed citations
5.
Chen, Fenqin, Shuai Xu, Yingfang Wang, et al.. (2020). Risk Factors for Sarcopenia in the Elderly with Type 2 Diabetes Mellitus and the Effect of Metformin. Journal of Diabetes Research. 2020. 1–10. 52 indexed citations
6.
Chen, Fenqin, Yingfang Wang, Tingting Liu, et al.. (2019). Risk factors for depression in elderly diabetic patients and the effect of metformin on the condition. BMC Public Health. 19(1). 1063–1063. 38 indexed citations
7.
Chen, Fenqin, et al.. (2019). The Mechanism of miR-192 in Regulating High Glucose-Induced MCP-1 Expression in Rat Glomerular Mesangial Cells. Endocrine Metabolic & Immune Disorders - Drug Targets. 19(7). 1055–1063. 9 indexed citations
8.
Chen, Fenqin, et al.. (2018). Naringin ameliorates the high glucose-induced rat mesangial cell inflammatory reaction by modulating the NLRP3 Inflammasome. BMC Complementary and Alternative Medicine. 18(1). 192–192. 51 indexed citations
9.
10.
Wu, Can, Chuan Lv, Fenqin Chen, et al.. (2015). The function of miR-199a-5p/Klotho regulating TLR4/NF-κB p65/NGAL pathways in rat mesangial cells cultured with high glucose and the mechanism. Molecular and Cellular Endocrinology. 417. 84–93. 44 indexed citations
11.
Zhou, Yuehong, Chuan Lv, Can Wu, et al.. (2014). Suppressor of cytokine signaling (SOCS) 2 attenuates renal lesions in rats with diabetic nephropathy. Acta Histochemica. 116(5). 981–988. 24 indexed citations
12.
Chen, Fenqin, et al.. (2014). Effects of mycophenolate mofetil on the expression of monocyte chemoattractant protein-1 and fibronectin in high glucose cultured human mesangial cells. Genetics and Molecular Research. 13(2). 3154–3161. 9 indexed citations
13.
Chen, Fenqin, Jiao Wang, Xiaobo Liu, et al.. (2013). Levels of Inflammatory Cytokines in Type 2 Diabetes Patients with Different Urinary Albumin Excretion Rates and Their Correlation with Clinical Variables. Journal of Diabetes Research. 2013. 1–6. 24 indexed citations
14.
Chen, Fenqin, et al.. (2012). [Effect of mycophenolate on expression of MCP-1 and fibronectin in human mesangial cells induced by high glucose].. PubMed. 28(5). 455–7. 1 indexed citations
15.
Wang, Qiuyue, et al.. (2009). The changes of platelet-derived growth factor-BB (PDGF-BB) in T2DM and its clinical significance for early diagnosis of diabetic nephropathy. Diabetes Research and Clinical Practice. 85(2). 166–170. 17 indexed citations
16.
Pan, Xiaodong, et al.. (2009). Prebiotic oligosaccharides change the concentrations of short-chain fatty acids and the microbial population of mouse bowel. Journal of Zhejiang University SCIENCE B. 10(4). 258–263. 133 indexed citations
17.
Wang, Qiuyue & Fenqin Chen. (2008). Clinical significance and different levels of urinary monocyte chemoattractant protein-1 in Type 2 diabetes mellitus. Diabetes Research and Clinical Practice. 83(2). 215–219. 25 indexed citations
18.
Pan, Xiaodong, et al.. (2008). The acid, bile tolerance and antimicrobial property of Lactobacillus acidophilus NIT. Food Control. 20(6). 598–602. 180 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hsin‐Yi Yang Breakdown of academic impact, for papers by Kohji Ohki Breakdown of academic impact, for papers by Yu‐Ling Tsai Breakdown of academic impact, for papers by Wanping Aw Breakdown of academic impact, for papers by Chu‐Chyn Ou Breakdown of academic impact, for papers by Farhad Koohpeyma Breakdown of academic impact, for papers by Jing Zhong Breakdown of academic impact, for papers by Nana Wang
Rankless by CCL
2026